GlassScriptPhysician profile
Joy L Murphy
NPI 1508959040
$1,602.26
in general payments reported to CMS, 2019-2025
14 companies · $578 in 2025
The $578 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.45 · 2022: $166 · 2023: $345 · 2024: $500 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $603.11 | 2022-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $301.34 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $218.50 | 2022-2025 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $86.02 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $74.19 | 2024-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $54.69 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $53.72 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.99 | 2022-2025 | Jardiance, Synjardy |
| Pfizer INC. | $45.61 | 2021-2024 | |
| Shield Therapeutics INC | $38.61 | 2023-2024 | Accrufer |
| Radius Health, INC. | $28.23 | 2025 | Tymlos |
| Boston Scientific Corporation | $19.62 | 2024 | Watchman Flx |
| Glaxosmithkline, LLC. | $16.28 | 2022 | |
| Heartflow, INC. | $14.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.